New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SI-BONE, Inc.
SIBN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

521M

Medical - Devices

Next Earning date - 12 Nov 2024

521M

Medical - Devices

Next Earning date - 12 Nov 2024

12.50USD
Shape-0.11 ( -0.87%)
Market Open
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

42%

Quote Panel

Shape
Updated October 25, 2024
1W -2.80 % 1M -9.34 % 3M -22.52 % 1Y -25.79 %

Key Metrics

Shape
  • Market Cap

    521.18M


  • Shares Outstanding

    41.69M


  • Share in Float

    36.72M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    12.5


  • Average Volume

    324517


  • Beta

    1.223


  • Range

    11.76-21.7


  • Industry

    Medical - Devices


  • Website

    https://si-bone.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.49x

P/S Ratio

3.16x

P/B Ratio

0.2

Debt/Equity

-27.1%

Net Margin

$-1.0

EPS

How SIBN compares to sector?

P/E Ratio

Relative Strength

Shape

SIBN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$195M

Shape387%

2025-Revenue

$0.75

Shape-241%

2025-EPS

$94M

Shape-939%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2024-03-28

Now: Overweight

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.41
vs -0.48

Q4.22

arrow
arrow

N/A

-0.32
vs -0.43

Q1.23

arrow
arrow

N/A

-0.32
vs -0.52

Q2.23

arrow
arrow

N/A

-0.30
vs -0.54

Q3.23

arrow
arrow

N/A

-0.25
vs -0.41

Q4.23

arrow
arrow

N/A

-0.27
vs -0.32

Q1.24

arrow
arrow

N/A

-0.27
vs -0.32

Q2.24

arrow
arrow

N/A

-0.22
vs -0.30

Q3.24

arrow
arrow

N/A

-0.24
vs -0.25

Q4.24

arrow
arrow

N/A

-0.17
vs -0.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+19%

26.4M  vs 22.3M

Q4.22

arrow
arrow

+27%

32M  vs 25.2M

Q1.23

arrow
arrow

+46%

32.7M  vs 22.4M

Q2.23

arrow
arrow

+30%

33.3M  vs 25.6M

Q3.23

arrow
arrow

+29%

34M  vs 26.4M

Q4.23

arrow
arrow

+22%

38.9M  vs 32M

Q1.24

arrow
arrow

+16%

37.9M  vs 32.7M

Q2.24

arrow
arrow

+20%

40M  vs 33.3M

Q3.24

arrow
arrow

+19%

40.5M  vs 34M

Q4.24

arrow
arrow

+22%

47.5M  vs 38.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.18

Q4.22

arrow
arrow

-11%

-0.11
vs -0.14

Q1.23

arrow
arrow

-11%

-0.11
vs -0.11

Q2.23

arrow
arrow

-6%

-0.06
vs -0.11

Q3.23

arrow
arrow

-6%

-0.06
vs -0.06

Q4.23

arrow
arrow

-6%

-0.06
vs -0.06

Q1.24

arrow
arrow

-7%

-0.07
vs -0.06

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

109

109
vs 108

1%

Q4.22

arrow
arrow

103

103
vs 109

-5%

Q1.23

arrow
arrow

122

122
vs 103

18%

Q2.23

arrow
arrow

171

171
vs 122

40%

Q3.23

arrow
arrow

151

151
vs 171

-12%

Q4.23

arrow
arrow

158

158
vs 151

5%

Q1.24

arrow
arrow

154

154
vs 158

-3%

Q2.24

arrow
arrow

144

144
vs 154

-6%

Earnings Growth

Latest News